|
Characteristics
|
Inpatients
|
Outpatients
|
|---|
| |
Total (n = 284 )
|
* Non- TB (n = 196)
|
TB (n = 88)
|
TB (n = 93)
|
|---|
|
Age, yr
|
63 ± 16.5
|
65 ± 14.5
|
59 ± 19.8
|
52 ± 19.5
|
|
Male
|
206 (72.5)
|
150 (76.5)
|
56 (63.6)
|
50 (53.8)
|
|
Body mass index
|
21.4 ± 3.50
|
21.7 ± 3.42
|
20.8 ± 3.61
|
21.7 ± 3.08
|
|
Prior TB history
|
57 (20.1)
|
39 (19.9)
|
18 (20.5)
|
16 (17.2)
|
|
Underlying conditions
| | | | |
|
Renal failure
|
11 (3.9)
|
9 (4.6)
|
2 (2.3)
|
0 (0)
|
|
Malignancy†
|
4 (1.4)
|
2 (1.0)
|
2 (2.3)
|
3 (3.2)
|
|
Immunosuppressive therapy‡
|
11 (3.9)
|
7 (3.6)
|
4 (4.5)
|
0 (0)
|
- Data are shown as mean ± SD or No. (%). TB, tuberculosis.
- * Patients with pneumonia (n = 178), organizing pneumonia (n = 7), nontuberculous mycobacterial lung disease (n = 5), aspergillosis (n = 4), and lung cancer (n = 2).
- † Patients with a diagnosis of cancer who were not receiving anti-cancer treatment, including lung cancer (n = 2), hypopharyngeal cancer (n = 1), and gastric cancer (n = 1) for inpatients; hepatocellular carcinoma (n = 1), glottic cancer (n = 1), and gastric cancer (n = 1) for outpatients.
- ‡ Patients receiving cancer chemotherapy (n = 9 ) or systemic steroids (>10 mg/day of prednisone for ≥ 1 month) (n = 2).
